🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DNA Methylation

Found 469 matching trials

Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients

PHASE2

Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...

Status

Completed

Location

AOU Careggi- University of Florence

Start Date

2021-03-24

Trial ID

NCT04806906

Treatments Being Tested

CC-486

Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program

Cervical cancer screening (CCS) is important to prevent and control cervica...

Status

Enrolling By Invitation

Location

Unidade Local de Saúde Gaia e Espinho

Start Date

2025-04-10

Trial ID

NCT06915610

Treatments Being Tested

Invitation of all participants to CCS according to the standard of care (active comparator)Invitation of all participants to CCS through self-sampling Invitation of all participants to CCS, asking them to choose between self-sampling and the standard of care Invitation of all participants to CCS according to the standard of care, followed by invitation of those non-adherent to CCS through self-sampling Invitation of all participants to CCS through self-sampling, followed by invitation of those non-adherent to CCS according to the standard of care Invitation of all participants to CCS, asking them to choose between self-sampling and the standard of care; this mode of invitation is repeated when participants do not adhere to the first invitation

Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study

N/A

The goal of this observational study is to investigate the genetic and epig...

Status

Not Yet Recruiting

Location

Konya Selcuk University Faculty of Medicine, Department of Child and Adolescent Psychiatry

Start Date

2025-12-27

Trial ID

NCT06662591

5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

PHASE1

This phase I trial is studying the side effects and best dose of 5-Fluoro-2...

Status

Completed

Location

City of Hope

Start Date

2009-12

Trial ID

NCT01041443

Treatments Being Tested

5-fluoro-2-deoxycytidine tetrahydrouridine laboratory biomarker analysis reverse transcriptase-polymerase chain reaction DNA methylation analysis

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

French prospective multicenter, open-label study involving newly diagnosed ...

Status

Recruiting

Location

CHU Annecy-Genevois

Start Date

2023-11-17

Trial ID

NCT06130787

Treatments Being Tested

Blood and bone marrow sample

Epigenetics of Muscle Insulin Resistance

N/A

The investigators are trying to understand the role of DNA (deoxyribonuclei...

Status

Completed

Location

University of Arizona

Start Date

2016-11

Trial ID

NCT03259984

Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

N/A

The goal of this observational study is to assess the effectiveness of the ...

Status

Recruiting

Location

Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario

Start Date

2023-10-19

Trial ID

NCT05804578

Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System

N/A

The purpose of this study is to verify whether the cell-free DNA of lung ca...

Status

Completed

Location

Peking University Third Hospital

Start Date

2017-12-01

Trial ID

NCT04454853

Treatments Being Tested

Lung cancer Suspected lung cancer Positive methylated DNA

Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection

N/A

Esophageal cancer is a highly aggressive malignancy with poor prognosis, ra...

Status

Completed

Location

Cancer hospital, Chinese academy of medical sciences

Start Date

2022-09-01

Trial ID

NCT06895551

Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease

N/A

BioGenParkinson is an observational, prospective cohort study evaluating bi...

Status

Unknown

Location

Multiple Locations

Start Date

2024-05-30

Trial ID

NCT05384522

Treatments Being Tested

blood samples collection

Previous Next